Ambient Biosciences has developed a groundbreaking stabilization technology that offers a more efficient alternative to traditional methods like lyophilization and cryopreservation for shipping and storing temperature-sensitive biomolecules. Their patented process allows for the stabilization of various biomolecules, including antibodies, enzymes, DNA/RNA, and small molecules, at room temperature. This innovative approach involves preparing biomolecules in a proprietary solution, which is then loaded into a microporous scaffold. The solution undergoes rapid drying, resulting in a vitrified state that maintains the activity of the biomolecules for extended periods, significantly reducing the risk of degradation during storage and transport.

The advantages of Ambient Biosciences' stabilization technology extend beyond just improved shelf life; it simplifies workflows and reduces costs associated with cold chain logistics. By eliminating the need for complex lyophilization protocols and specialized training, the technology allows for easier implementation across various biomolecule classes. Users can produce larger lot sizes with extended expiration dates, minimizing waste and enhancing operational efficiency. This user-friendly process not only streamlines product development but also enhances the overall customer experience by reducing shipping fees and the need for freezer storage, making it a valuable solution for the biotherapeutics and research sectors.

United States

At Ambient Biosciences, we are dedicated to being a true partner in your success. We bring the same spirit of versatility, transparency, and innovation to our customer relationships as we do to our technology. Our approach is to take the mystery out of biomolecule stabilization, making it an accessible and collaborative process that empowers you to feel confident about your products and assays.

Ambient Biosciences

Company Details